ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

?-catenin promotes resistance to trastuzumab in breast cancer cells through enhancing interaction between HER2 and SRC

Hao, Xiaoyan; Zheng, Jialu; Yu, Xiaoqin; Li, Zhixin; Ren, Guanghui*南方医科大学
ACTA BIOCHIMICA POLONICA2023DOI: 10.18388/abp.2020_6357
1被引17阅读
引用收藏
分享

摘要

More than 1 million women worldwide are diagnosed with breast cancer (BC) each year. This study aims to explore the molecular mechanisms of beta-catenin affect-ing the trastuzumab tolerance in HER2-positive BC. beta-catenin in BC and non-BC tissue samples were as-sessed by immunohistochemistry. beta-catenin and HER2 were over-expressed and knockdown to evaluate their role in tumorigenicity and trastuzumab resistance in cell and animal models using soft-agar and xenograft assays. Confocal laser immunofluorescence assay and co-immunoprecipitation were used to assess protein -protein binding. Expression of genes was detected using Western blot analysis. beta-catenin was highly expressed in primary and metastatic BC, overexpression of beta-catenin increased the colony formation of MCF7 cells when it was co-expressed with HER2 and synergically increased the tumor size in immunodeficient mice. Overexpression of beta-catenin also increased the phosphorylation of HER2 and HER3 and increased the size of tumor derived from HER2-elevated cells. Confocal laser immunofluorescence assay showed that beta-catenin and HER2 were co-localized on the membrane of MDA-MB-231 cells, suggesting that beta-catenin binds HER2 to activate the HER2 signaling pathway. Immunoprecipitation of beta-catenin and HER2 also confirmed this binding. On the other hand, knock-down of beta-catenin in MDA-MB-231 cell lines decreased the activity of SRC and decreased phosphorylation of HER2 at Y877 and Y1248. The interaction between HER2 and SRC was enhanced when beta-catenin was overex-pressed, and beta-catenin increased the resistance of tumor derived from HER2 elevated BT474 cells to trastuzumab. Further analysis showed that trastuzumab inhibited the activation of HER3, but SRC was still highly expressed in cells overexpressing beta-catenin. Our work demonstrates that beta-catenin is highly expressed in BC and it synergi-cally promotes formation and progress of BC with HER2. beta-catenin binds with HER2 leading to enhanced interac-tion with SRC and resistance to trastuzumab.

学科与关键词

关键词
?-cateninHER2-positive BCtrastuzumabdrug resist-ance
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
ACTA BIOCHIMICA POLONICA
发表日期
2023
卷期
第 70 卷, 第 2 期
页码
261-269
DOI
10.18388/abp.2020_6357
语言
ENGLISH
成果收录
SCIE

作者

  • H

    Hao, Xiaoyan (第一作者)

  • Z

    Zheng, Jialu

查看全部 5 位作者收起作者
  • Y

    Yu, Xiaoqin

  • L

    Li, Zhixin

  • R

    Ren, Guanghui (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417